Specialty generics spin-off along with Amitiza brand. Levered spin, with the spun-off entity carrying the opioids liability expected to run for the next few yea
Charitable assistance for co-pays has come under scrutiny and appears to be boiling over. Mallinckrodt's response to Citron has raised a red flag about the rela
Mallinckrodt Plc (NYSE:MNK) BMO Prescriptions for Success Healthcare Conference December 12, 2018, 08:00 AM ET Executives Dan Speciale - IR Mark Trudeau - CEO S
Mallinckrodt plc’s (NYSE:MNK) subsidiary, SpecGx LLC reported that the FDA has issued a complete response letter (“CRL”) for its new drug application...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Buy||Sell||Sell||Strong Sell||Strong Sell|
|Technical Indicators||Strong Buy||Strong Buy||Strong Sell||Strong Sell||Strong Sell|
|Summary||Strong Buy||Neutral||Strong Sell||Strong Sell||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Bullish Engulfing||1H||1||Dec 17, 2018 02:00PM|
|Three Inside Up||30||2||Dec 17, 2018 02:30PM|
|Three Black Crows||1W||3||Nov 25, 2018|
Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.Read More
|U.S. Commodity Futures Trading Commission (United States)||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$2000||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.